CEO (Chief Executive Officer) since 2008

Employment test 1 - 10 employees
Company dna neniveh gmbh
operating since 2008
22.23
Headquarter in Berlin and 2 offices
active in Legal Services, IP Consulting, IPR-related Financial Service, and IP-related Communication Service

Partner/Owner
Representative before the EPO

Employment test 1 - 10 employees
Company dna schulz junghans
no operation time available
Headquarter in Berlin
active in Legal Services

We have observed 30 EP applications Claas Junghans has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13163191

Process for preparation of Bendamustine

IPC classification:
A61K 31/4184, A61P 35/00, C07D 235/16
Applicant:
HEYL Chemisch-Pharmazeutische Fabrik GmbH und Co. KG
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12731316

DEVICE AND METHOD FOR PRODUCING A COLD, HOMOGENEOUS PLASMA UNDER ATMOSPHERIC PRESSURE CONDITIONS

IPC classification:
H05H 1/24
Applicant:
Leibniz-Institut für Plasmaforschung und Technologie e. V. INP Greifswald
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Agent:
Helmut Wehlan, Patentanwälte Wehlan & Wehlan
Status:
GRANT OF PATENT INTENDED
EP12732995

ANTIGEN-SPECIFIC CENTRAL-MEMORY T CELL PREPARATIONS HAVING HIGH CD4+ FRACTION

IPC classification:
C12N 5/0783
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP12192465

Bispecific HER2 ligands for cancer therapy

IPC classification:
A61K 47/48, C07K 14/47
Applicant:
University of Zurich (Universität Zürich)
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12191830

Phosphorescent dye and phosphorescence immunoassay by peptide displacement

IPC classification:
C07D 471/04, C12Q 1/68, G01N 21/64, G01N 33/533, G01N 33/58, G01N 33/68
Applicant:
Universität Leipzig KöR
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12735122

FELINE LEUKEMIA VIRUS TRANS-MEMBRANE PROTEIN P15E FOR DIAGNOSIS OF FELV INFECTION

IPC classification:
G01N 33/569
Applicant:
University of Zurich (Universität Zürich)
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12780684

COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY

IPC classification:
A61K 38/20, A61K 39/395, A61K 45/06, A61P 35/00
Applicant:
University of Zurich (Universität Zürich)
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12772882

PHARMACEUTICAL COMPOUNDS FOR USE IN THE THERAPY OF CLOSTRIDIUM DIFFICILE INFECTION

IPC classification:
C07F 9/117
Applicant:
Federal Institute of Technology Zurich (Eidgenössische Technische Hochschule Zürich)
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13157998

Water-insoluble Ruthenium catalyst composition for use in aqueous hydrogenation reactions

IPC classification:
B01J 31/24, C07C 29/145
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12806729

TWO-PART WALL-MOUNTABLE ELECTROCHEMICAL DISPENSER

IPC classification:
A61L 9/12
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12159716

Tricyclic nucleosides and oligomeric compounds prepared therefrom

IPC classification:
C07H 19/06, C07H 21/00
Applicant:
University of Bern (Universität Bern)
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Agent:
Martin Sperrle, Latscha Schöllhorn Partner AG
Status:
EXAMINATION IN PROGRESS
EP13174786

Phosphorescence-based hydrogen peroxide assay for the detection of hydrogen peroxide in human serum and water samples

IPC classification:
C12Q 1/26, C12Q 1/54, C12Q 1/60
Applicant:
Universität Leipzig KöR
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13174551

Organometallic 2-cyano-2-aminobenzoate-propyl derivates and their use as anthelmintics

IPC classification:
A01N 37/34, C07F 17/02
Applicant:
University of Zurich (Universität Zürich)
Applicant:
University of Melbourne
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12174673

Psoralen derivatives for the treatment of heart failure and heart hypertophy

IPC classification:
A61K 31/35, A61P 9/00, A61P 9/04, A61P 9/12
Applicant:
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12198835

Fluid system with absorbent and reversible polymer gel

IPC classification:
B01L 3/00, F16K 99/00
Applicant:
University of Potsdam (Universität Potsdam)
Applicant:
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Agent:
Christian Haggenmüller, Maiwald Patentanwalts GmbH
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP12184915

Process for the production of magnesium fluoride sol solutions from alkoxides comprising addition of carbon dioxide

IPC classification:
C01B 9/08, C01F 5/28, H01L 31/0216
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12184916

Process for production of magnesium fluoride sol solutions from alkoxides comprising addition of magnesium salts

IPC classification:
C01B 9/08, C01F 5/28, C03C 17/22, H01L 31/0216
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13187194

Human trypsinogen with reduced autoactivation and its use in an immunoassay

IPC classification:
C12N 9/76, C12Q 1/37, G01N 33/542, G01N 33/58
Applicant:
Universität Leipzig Forschungskontaktstelle
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13713618

ELECTRONIC MONITORING HOME UNIT AND INSTALLATION METHODS

IPC classification:
G08B 21/02, G08B 21/22, G08B 25/08
Applicant:
3M Innovative Properties Company
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13742406

PSORALEN DERIVATIVES FOR PREVENTING OR TREATING HEART FAILURE OR CARDIAC HYPERTROPHY

IPC classification:
A61K 31/35, A61P 9/00, A61P 9/04, A61P 9/12
Applicant:
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15819433

SELF-ADMINISTERED TAMPER-EVIDENT DRUG DETECTION

IPC classification:
A61B 5/117
Applicant:
3M Innovative Properties Company
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15750743

HIGHLY MULTIPLEXED ABSOLUTE QUANTIFICATION OF MOLECULES ON THE SINGLE CELL LEVEL

IPC classification:
G01N 33/50, G01N 33/58, G01N 33/68
Applicant:
University of Zurich (Universität Zürich)
Applicant:
ETH Transfer
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15750621

HYPERVALENT IODINE CF2CF2X REAGENTS AND THEIR USE

IPC classification:
C07D 347/00
Applicant:
ETH Transfer
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15787451

MEANS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISEASES

IPC classification:
A01K 67/027, A61K 51/12, C12N 5/0789
Applicant:
Charite Universitätsmedizin Berlin
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
Request for examination was made
EP15865547

COMPOSITIONS AND METHODS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES

IPC classification:
A61K 31/40, A61K 38/05, A61P 25/28, A61P 27/02
Applicant:
Mor Research Applications Ltd.
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
Request for examination was made
EP15817126

GRAFT SCAFFOLD FOR CARTILAGE REPAIR AND PROCESS FOR MAKING SAME

IPC classification:
A61L 27/20, A61L 27/36, A61L 27/38, A61L 27/46, A61L 27/48, B29C 67/00, B33Y 10/00
Applicant:
Federal Institute of Technology Zurich (Eidgenössische Technische Hochschule Zürich)
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
Request for examination was made
EP15817277

CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE

IPC classification:
C07K 14/725, C07K 14/74, C12N 5/0783
Applicant:
Federal Institute of Technology Zurich (Eidgenössische Technische Hochschule Zürich)
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
Request for examination was made
EP15880177

TRANSFORMED FUNGUS HAVING ENHANCED ERGOTHIONEINE PRODUCTIVITY AND METHOD FOR PRODUCING ERGOTHIONEINE

IPC classification:
C12N 1/15, C12N 9/10, C12N 15/09, C12P 13/04, C12R 1/66, C12R 1/665, C12R 1/685, C12R 1/69
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
Request for examination was made
EP16701645

AGONISTS OF THE NOGO-A S1PR PATHWAY FOR THE TREATMENT OF GLIOBLASTOMA

IPC classification:
A61K 38/17, A61P 35/00
Applicant:
University of Zurich (Universität Zürich)
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
Request for examination was made
EP16703507

USE OF HLA-B27 HOMODIMERS FOR CANCER TREATMENT

IPC classification:
A61K 39/00
Applicant:
University of Zurich (Universität Zürich)
Applicant:
University of Basel (Universität Basel)
Agent:
Claas Junghans, Schulz Junghans Patentanwälte PartGmbB
Status:
Request for examination was made

Please Sign in to use this feature